CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-23 | GIVEN BRUCE D Chief Operating Officer | Sale | −17,500 | $13.15 | $230K | 898,856 |
| 2019-01-22 | GIVEN BRUCE D Chief Operating Officer | Sale | −152,000 | $13.59 | $2.1M | 916,356 |
| 2019-01-22 | GIVEN DOUGLAS B Director | Sale | −3,000 | $13.58 | $41K | 178,130 |
| 2019-01-18 | O'Brien Patrick General Counsel | Sale | −72,000 | $14.43 | $1.0M | 233,000 |
| 2019-01-17 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −81,875 | $14.55 | $1.2M | 305,607 |
| 2019-01-14 | Li Zhen Snr. VP, Chem and Non-Clin Dev | Sale | −40,500 | $14.34 | $581K | 201,700 |
| 2019-01-14 | GIVEN BRUCE D Chief Operating Officer | Option exercise | +11,666 | $2.62 | $31K | 1,110,022 |
| 2019-01-14 | GIVEN BRUCE D Chief Operating Officer | Option exercise | +1,000 | $6.20 | $6K | 1,111,022 |
| 2019-01-14 | GIVEN BRUCE D Chief Operating Officer | Sale | −42,666 | $14.40 | $614K | 1,068,356 |
| 2019-01-14 | GIVEN BRUCE D Chief Operating Officer | Option exercise · Stock Option (right to buy) | −11,666 | 544,334 | ||
| 2019-01-14 | GIVEN BRUCE D Chief Operating Officer | Option exercise · Stock Option (right to buy) | −1,000 | 543,334 | ||
| 2019-01-11 | Waddill William D. Director | Sale | −8,500 | $14.77 | $126K | 46,500 |
| 2019-01-02 | Ferrari Mauro Director | Grant or award | +3,429 | 19,656 | ||
| 2019-01-02 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −8,333 | $11.98 | $100K | 387,482 |
| 2019-01-02 | GIVEN BRUCE D Chief Operating Officer | Sale | −20,000 | $11.98 | $240K | 1,098,356 |
| 2019-01-01 | Waddill William D. Director | Grant or award | +30,000 | 55,000 | ||
| 2019-01-01 | PERRY MICHAEL S Director | Grant or award | +36,000 | 221,000 | ||
| 2019-01-01 | GIVEN DOUGLAS B Director | Grant or award | +36,000 | 181,130 | ||
| 2019-01-01 | Li Zhen Snr. VP, Chem and Non-Clin Dev | Grant or award | +75,000 | 242,200 | ||
| 2019-01-01 | O'Brien Patrick General Counsel | Grant or award | +70,000 | 305,000 |
Page 32 of 38 · 752 trades